These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 32181526)

  • 21. Increased expression of REG3A promotes tumorigenic behavior in triple negative breast cancer cells.
    Jin X; Yang S; Lu X; Chen X; Dai W
    Breast Cancer Res; 2024 Jun; 26(1):92. PubMed ID: 38840145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRPC1 inhibits the proliferation and migration of estrogen receptor-positive Breast cancer and gives a better prognosis by inhibiting the PI3K/AKT pathway.
    Zhang LY; Zhang YQ; Zeng YZ; Zhu JL; Chen H; Wei XL; Liu LJ
    Breast Cancer Res Treat; 2020 Jul; 182(1):21-33. PubMed ID: 32415497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA‑27a promotes tumorigenesis via targeting AKT in triple negative breast cancer.
    Wu J; Sun Z; Sun H; Li Y
    Mol Med Rep; 2018 Jan; 17(1):562-570. PubMed ID: 29115608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role and Mechanism of CRT0066101 as an Effective Drug for Treatment of Triple-Negative Breast Cancer.
    Liu Y; Wang Y; Yu S; Zhou Y; Ma X; Su Q; An L; Wang F; Shi A; Zhang J; Chen L
    Cell Physiol Biochem; 2019; 52(3):382-396. PubMed ID: 30845378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of cancerous progression by LISCH7 via direct stimulation of TGFB1 transcription in triple-negative breast cancer.
    Tang X; Zhou Y; Liu Y; Zhang W; Liu C; Yan C
    J Cell Biochem; 2020 Nov; 121(11):4642-4653. PubMed ID: 32048750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
    Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
    Li M; Li A; Zhou S; Lv H; Yang W
    J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer.
    Sriramulu S; Thoidingjam S; Chen WM; Hassan O; Siddiqui F; Brown SL; Movsas B; Green MD; Davis AJ; Speers C; Walker E; Nyati S
    J Exp Clin Cancer Res; 2024 Jun; 43(1):163. PubMed ID: 38863037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-SMC Condensin I Complex Subunit D2 Is a Prognostic Factor in Triple-Negative Breast Cancer for the Ability to Promote Cell Cycle and Enhance Invasion.
    Zhang Y; Liu F; Zhang C; Ren M; Kuang M; Xiao T; Di X; Feng L; Fu L; Cheng S
    Am J Pathol; 2020 Jan; 190(1):37-47. PubMed ID: 31610177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual Inhibition of Key Proliferation Signaling Pathways in Triple-Negative Breast Cancer Cells by a Novel Derivative of Taiwanin A.
    Kuo YH; Chiang EI; Chao CY; Rodriguez RL; Chou PY; Tsai SY; Pai MH; Tang FY
    Mol Cancer Ther; 2017 Mar; 16(3):480-493. PubMed ID: 27956520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serous IFNA3 predicts unfavorable prognosis in lung cancer via abnormal activation of AKT signaling.
    Ge Q; Cong P; Ji Y
    IUBMB Life; 2019 Nov; 71(11):1806-1814. PubMed ID: 31419016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-193 promotes cell proliferation and invasion by ING5/PI3K/AKT pathway of triple-negative breast cancer.
    Xu JH; Zhao JX; Jiang MY; Yang LP; Sun ML; Wang HW
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3122-3129. PubMed ID: 32271430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of TMPRSS4 Enhances Triple-Negative Breast Cancer Cell Radiosensitivity Through Cell Cycle and Cell Apoptosis Process Impairment.
    Assani G; Segbo J; Yu X; Yessoufou A; Xiong Y; Zhou F; Zhou Y
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3679-3687. PubMed ID: 31870109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy.
    López-Ozuna VM; Hachim IY; Hachim MY; Lebrun JJ; Ali S
    Sci Rep; 2016 Aug; 6():30934. PubMed ID: 27480353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor.
    Tzeng HE; Yang L; Chen K; Wang Y; Liu YR; Pan SL; Gaur S; Hu S; Yen Y
    Oncotarget; 2015 May; 6(13):11061-73. PubMed ID: 25857298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer.
    Gagliardi M; Pitner MK; Park J; Xie X; Saso H; Larson RA; Sammons RM; Chen H; Wei C; Masuda H; Chauhan G; Kondo K; Tripathy D; Ueno NT; Dalby KN; Debeb BG; Bartholomeusz C
    Sci Rep; 2020 May; 10(1):8537. PubMed ID: 32444778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SLC6A8-mediated intracellular creatine accumulation enhances hypoxic breast cancer cell survival via ameliorating oxidative stress.
    Li Q; Liu M; Sun Y; Jin T; Zhu P; Wan X; Hou Y; Tu G
    J Exp Clin Cancer Res; 2021 May; 40(1):168. PubMed ID: 33990217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA DANCR upregulates PI3K/AKT signaling through activating serine phosphorylation of RXRA.
    Tang J; Zhong G; Zhang H; Yu B; Wei F; Luo L; Kang Y; Wu J; Jiang J; Li Y; Wu S; Jia Y; Liang X; Bi A
    Cell Death Dis; 2018 Dec; 9(12):1167. PubMed ID: 30518934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
    Ring A; Kaur P; Lang JE
    BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.